El Paso, TX, United States
MXBBB recalls
1 recall recorded since 2018, most recently on 14 November 2024. 1 is listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)1
Terminated or completed0
Class I (FDA)0
Ongoing Class II Drugs
- Recall started
- 14 November 2024
- Reason
- cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.
- Distribution
- Product was sold via Amazon Marketplace.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0166-2025
- UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.